Literature DB >> 25291961

Aspartate aminotransferase-to-platelet ratio index is associated with liver cirrhosis in patients undergoing surgery for hepatocellular carcinoma.

Mitsuru Ishizuka1, Keiichi Kubota2, Junji Kita2, Mitsugi Shimoda2, Masato Kato2, Shozo Mori2, Yukihiro Iso2, Hidetsugu Yamagishi3, Masaru Kojima3.   

Abstract

BACKGROUND: Among various preoperative evaluations of liver function, accurate assessment of liver cirrhosis (LC) is especially important in patients undergoing surgery for hepatocellular carcinoma (HCC).
OBJECTIVE: To explore the most significant laboratory parameter associated with LC in patients undergoing surgery for HCC.
METHODS: From among 588 HCC patients in our collected database who underwent liver surgery, 371 for whom sufficient laboratory data were evaluable, including direct serum fibrosis markers such as hyaluronic acid and type 3 procollagen peptide (P-3-P), were enrolled. Receiver operating characteristic (ROC) curve analysis was used to define the ideal cutoff values of laboratory parameters, and the area under the ROC curve for LC was measured. Univariate and multivariate analyses were performed to clarify the laboratory parameter most significantly associated with LC.
RESULTS: Multivariate analysis of 13 laboratory parameters that had been selected by univariate analysis showed that the aspartate aminotransferase-to-platelet ratio index (APRI) (≤ 0.8/>0.8) (odds ratio, 2.687; 95% confidence interval 1.215-5.940; P = 0.015) was associated with LC, along with the aspartate aminotransferase to alanine aminotransferase ratio, the indocyanine green retention ratio at 15 min (ICG R15), and the level of hyaluronic acid. Among these four parameters associated with LC, ROC curve analysis revealed that APRI (0.757) had the largest area under the ROC (aspartate aminotransferase to alanine aminotransferase 0.505, ICG R15 0.714, and hyaluronic acid 0.743).
CONCLUSIONS: APRI is closely associated with LC in patients undergoing surgery for HCC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aspartate aminotransferase-to-platelet ratio index; Fibrosis marker; Hepatocellular carcinoma; Liver cirrhosis

Mesh:

Substances:

Year:  2014        PMID: 25291961     DOI: 10.1016/j.jss.2014.09.009

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  MEK1 expression and its relationship with clinical pathological features in hepatocellular carcinoma.

Authors:  Renhua Gong; Dengqun Sun; Xingguo Zhong; Yanjun Sun; Li Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Evaluation of Aspartate Aminotransferase-to-Platelet Ratio Index as a Non-Invasive Marker for Liver Cirrhosis.

Authors:  Princi Jain; B K Tripathi; B Gupta; Bharti Bhandari; Divesh Jalan
Journal:  J Clin Diagn Res       Date:  2015-11-01

3.  Kaempferol and Chrysin Synergies to Improve Septic Mice Survival.

Authors:  Omar A Harasstani; Chau Ling Tham; Daud A Israf
Journal:  Molecules       Date:  2017-01-06       Impact factor: 4.411

4.  Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy.

Authors:  Yifan Han; Jianxiang Liu; Jiali Pan; Hongyu Chen; Ning Tan; Qian Kang; Yuqing Yang; Xiaoyuan Xu; Wengang Li
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

5.  Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index.

Authors:  Kelvin Allenson; David Roife; Lillian S Kao; Tien C Ko; Curtis J Wray
Journal:  J Gastrointest Oncol       Date:  2020-04

6.  Chromosome region maintenance 1 expression and its association with clinical pathological features in primary carcinoma of the liver.

Authors:  Qiao-Ling Xie; Yue Liu; Ying Zhu
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

7.  Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma.

Authors:  Shu-Yein Ho; Po-Hong Liu; Chia-Yang Hsu; Cheng-Yuan Hsia; Chien-Wei Su; Yi-Jhen He; Yun-Hsuan Lee; Yi-Hsiang Huang; Ming-Chih Hou; Teh-Ia Huo
Journal:  Sci Rep       Date:  2018-10-10       Impact factor: 4.379

8.  Longitudinal increase in albumin-bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis.

Authors:  Akira Sakamaki; Masaaki Takamura; Norihiro Sakai; Yusuke Watanabe; Yoshihisa Arao; Naruhiro Kimura; Toru Setsu; Hiroyuki Abe; Takeshi Yokoo; Hiroteru Kamimura; Shunsuke Tsubata; Nobuo Waguri; Toru Ishikawa; Hirokazu Kawai; Soichi Sugitani; Tomomi Sato; Kazuhiro Funakoshi; Masashi Watanabe; Kentarou Igarashi; Kenya Kamimura; Atsunori Tsuchiya; Yutaka Aoyagi; Shuji Terai
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.